James Larrick

Founded in 2001 by Stephen Brozak, WBB Securities LLC is an SEC-registered broker/dealer headquartered in San Diego, California. Their services include order execution, back office administration and research. The firm follows the biotechnology, medical devices and healthcare industries. WBB Securities is a member of FINRA, the NASD and the SIPC.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

180 Life Sciences Corp. engages in manufacture of pharmaceutical products. The company is headquartered in New York.

Lupus Research Alliance, Inc. provides research and development for the treatment of lupus disease. The company is headquartered in New York, NY.

Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

ReFormation Pharmaceuticals Corp. operates as a medical marijuana pharmaceutical company. It focuses on repairing vital organs by combining cannabinoids and an endogenous trigger of repair. The company was founded by Marc Feldmann and Jagdeep Nanchahal and is headquartered in Toronto, Canada.

CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada.

Part of University of Oxford, Kennedy Institute of Rheumatology is a research facility that focuses on studying host-microbe crosstalk in health and disease, with a particular emphasis on inflammatory bowel disease, colorectal cancer, and inflammatory arthritis. The Kennedy Institute of Rheumatology is based in Headington, UK. The institute employs advanced microscopy methods and cutting-edge technology to generate a wide variety of data, which is made available to researchers through the Research Informatics team. The facility aims to future-proof excellence for Bioimaging within Oxford, keeping it competitive with international research.

Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA.

Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021.